Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage
COVID CALL 15
1 other identifier
observational
12,000,000
1 country
1
Brief Summary
A coronavirus pandemic began on 12/31/2020 with the first Chinese patient. As of 3/16/2020, the epidemic affects more than 100 countries with 169,000 official infections and 6,500 deaths. This virus causes a pathology ranging from simple flu symptoms in 80% of cases to acute respiratory distress syndromes requiring resuscitation in 5% of cases and a death rate of 1.4 to 4% of cases. The arrival in France on 02/25/2020 with an exponential development of the infection (more than 5,000 cases on 03/15/2020) was accompanied by an unprecedented number of calls to the French emergency service call number (15) of worried patients with overload and sometimes saturation of the service that can impact calls and the care of patients really recovering from an emergency. We previously developed a Moovcare® web application which showed a 7 months survival benefit by early detection of relapsed lung cancer based on the reporting of patient symptoms analyzed by a validated algorithm in 300 patients and 1 trial randomized. Another application for detecting and monitoring chemo-induced febrile aplasia appears to show a reduction in the number of hospitalizations for sepsis. Finally, Smokecheck, a self-assessment application for symptoms by smokers, has shown that it improves the detection of symptomatic operable bronchial cancers (9 to 24%, p = 0.04). The web application https://www.maladiecoronavirus.fr/ was developed with a group of physicians from the Institut Pasteur, Hospitals group of Paris, Hospitals of Lille and Rennes and the ILC Jean Bernard in Le Mans. It makes it possible to guide symptomatic patients and patients who wishing to know what to do (call their general practitioner, teleconsultation, or call emergency service) based on symptoms and predictive factors of severity. Following the availability of this new tool, we want to assess the impact of the application on the number and relevance of calls to emergency service.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2020
CompletedFirst Submitted
Initial submission to the registry
March 30, 2020
CompletedFirst Posted
Study publicly available on registry
April 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2020
CompletedApril 8, 2021
April 1, 2021
8 months
March 30, 2020
April 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
To assess of the evolution of the number of calls to Emergency service within 12 days after the launch of the application https://www.maladiecoronavirus.fr/
Number of calls to Emergency service after the launch of web application comparded to the days before
12 days
To assess of the evolution of the proportion of relevant calls to Emergency service within 12 days after the launch of the application https://www.maladiecoronavirus.fr/
Number of relevants calls to Emergency service after the launch of web application comparded to the days before
12 days
Secondary Outcomes (4)
To assess the evolution over time of the COVID 19 epidemic
3 months
To assess the evolution over space of the COVID 19 epidemic
3 months
To assess symptoms
3 months
To assess the users population
3 months
Study Arms (1)
Web-application users
questionnaire of comorbidity and symptomes completed by the user on his smartphone
Interventions
questionnaire of comorbidity and symptoms completed by the patient on his smartphone
Eligibility Criteria
All users of the https://www.maladiecoronavirus.fr/ application over the age of 18
You may qualify if:
- All users of the https://www.maladiecoronavirus.fr/ application over the age of 18
You may not qualify if:
- not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wepromlead
- Institut Pasteurcollaborator
- Assistance Publique - Hôpitaux de Pariscollaborator
- DOCAPOSTcollaborator
- Direction Générale de l'Offre de Soinscollaborator
Study Sites (1)
All French Emergency services
Le Mans, France
Related Publications (3)
Denis F, Fontanet A, Le Douarin YM, Le Goff F, Jeanneau S, Lescure FX. A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study. J Med Internet Res. 2021 Mar 12;23(3):e26182. doi: 10.2196/26182.
PMID: 33709945DERIVEDGalmiche S, Rahbe E, Fontanet A, Dinh A, Benezit F, Lescure FX, Denis F. Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study. J Med Internet Res. 2020 Nov 23;22(11):e22924. doi: 10.2196/22924.
PMID: 33147165DERIVEDDenis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX. Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application. J Med Internet Res. 2020 Jun 11;22(6):e19855. doi: 10.2196/19855.
PMID: 32496206DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fabrice DENIS, MD
Jean Bernard Center - LE MANS
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2020
First Posted
April 2, 2020
Study Start
March 17, 2020
Primary Completion
November 15, 2020
Study Completion
November 15, 2020
Last Updated
April 8, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share